Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
0.4610
-0.0012 (-0.26%)
Jan 12, 2026, 10:40 AM EST - Market open
Propanc Biopharma Balance Sheet
Financials in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2016 - 2020 |
Cash & Equivalents | 0.6 | 0.01 | 0.02 | 0.01 | 0 | 0 | Upgrade |
Cash & Short-Term Investments | 0.6 | 0.01 | 0.02 | 0.01 | 0 | 0 | Upgrade |
Cash Growth | 6403.42% | -42.67% | 109.86% | 147.04% | 80.36% | -96.64% | Upgrade |
Other Receivables | 0.01 | 0.01 | 0 | 0 | 0 | 0 | Upgrade |
Receivables | 0.01 | 0.01 | 0 | 0 | 0 | 0 | Upgrade |
Prepaid Expenses | 8.14 | 8.33 | - | 0.01 | 0.01 | - | Upgrade |
Other Current Assets | 0.01 | 0 | 0 | - | - | - | Upgrade |
Total Current Assets | 8.76 | 8.35 | 0.03 | 0.02 | 0.02 | 0.01 | Upgrade |
Property, Plant & Equipment | 0.06 | 0.06 | 0.02 | 0.04 | 0.06 | 0 | Upgrade |
Long-Term Deferred Charges | 0.02 | 0.29 | 0.03 | - | - | - | Upgrade |
Other Long-Term Assets | 9.14 | 10.93 | 0 | 0 | 0 | 0 | Upgrade |
Total Assets | 17.98 | 19.63 | 0.07 | 0.06 | 0.08 | 0.01 | Upgrade |
Accounts Payable | 1.07 | 1.25 | 1.21 | 0.97 | 0.94 | 1 | Upgrade |
Accrued Expenses | 1.68 | 2.35 | 1.53 | 1.21 | 0.94 | 1.31 | Upgrade |
Short-Term Debt | 0.63 | 1.56 | 0.87 | 0.51 | 0.98 | 0.68 | Upgrade |
Current Portion of Leases | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | - | Upgrade |
Other Current Liabilities | 0.17 | 0.4 | 0.16 | 0.45 | 0.18 | 0.09 | Upgrade |
Total Current Liabilities | 3.57 | 5.58 | 3.79 | 3.16 | 3.06 | 3.08 | Upgrade |
Long-Term Debt | - | 0.11 | 0.06 | - | - | - | Upgrade |
Long-Term Leases | 0.04 | 0.04 | - | 0.02 | 0.04 | - | Upgrade |
Total Liabilities | 3.61 | 5.73 | 3.85 | 3.18 | 3.11 | 3.08 | Upgrade |
Common Stock | 0.01 | 0.01 | 0 | 0.01 | 0 | 0.01 | Upgrade |
Additional Paid-In Capital | 143.52 | 138.24 | 61.7 | 60.31 | 57.36 | 54.07 | Upgrade |
Retained Earnings | -130.46 | -125.62 | -66.7 | -64.68 | -61.56 | -58.2 | Upgrade |
Treasury Stock | -0.05 | -0.05 | -0.05 | -0.05 | -0.05 | -0.05 | Upgrade |
Comprehensive Income & Other | 1.34 | 1.32 | 1.27 | 1.29 | 1.21 | 1.09 | Upgrade |
Total Common Equity | 14.36 | 13.91 | -3.78 | -3.12 | -3.03 | -3.07 | Upgrade |
Shareholders' Equity | 14.36 | 13.91 | -3.78 | -3.12 | -3.02 | -3.07 | Upgrade |
Total Liabilities & Equity | 17.98 | 19.63 | 0.07 | 0.06 | 0.08 | 0.01 | Upgrade |
Total Debt | 0.7 | 1.73 | 0.95 | 0.55 | 1.04 | 0.68 | Upgrade |
Net Cash (Debt) | -0.09 | -1.71 | -0.93 | -0.54 | -1.04 | -0.68 | Upgrade |
Net Cash Per Share | -0.01 | -0.43 | - | - | - | - | Upgrade |
Filing Date Shares Outstanding | 13.36 | 12.81 | 0.01 | - | - | - | Upgrade |
Total Common Shares Outstanding | 12.81 | 11.61 | - | - | - | - | Upgrade |
Working Capital | 5.19 | 2.77 | -3.77 | -3.14 | -3.05 | -3.07 | Upgrade |
Book Value Per Share | 1.12 | 1.20 | - | - | - | - | Upgrade |
Tangible Book Value | 14.36 | 13.91 | -3.78 | -3.12 | -3.03 | -3.07 | Upgrade |
Tangible Book Value Per Share | 1.12 | 1.20 | - | - | - | - | Upgrade |
Machinery | 0.03 | - | - | 0.03 | 0.03 | 0.03 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.